Your fact-checks will appear here
Female given name
No dementia drug developed or publicly tied to Elon Musk has received FDA or EMA approval as of December 2025 in the available reporting. Neuralink — the Musk-associated company most often linked to n...
Garadacimab (Andembry®, garadacimab‑gxii) is approved in several markets for prevention of hereditary angioedema (HAE) based on pivotal Phase 3 data from the global VANGUARD trial and supporting Phase...
Ivermectin overdoses in humans can cause gastrointestinal effects (nausea, vomiting, diarrhea), cardiovascular collapse (hypotension), and a range of neurologic harms including dizziness, ataxia, conf...
Lipoless is a name used for several different products with different active ingredients: a prescription injectable branded “LIPOLESS” that lists tirzepatide (a dual GLP-1/GIP agonist) as its active i...
As of the sources through 2025, there are no FDA‑approved generic or biosimilar versions of tirzepatide (sold as Mounjaro/Zepbound); multiple industry and regulatory notices say generics are not avail...
Lipoless is a brand name used for several different products with different active ingredients: an injectable product sold as “Lipoless” lists tirzepatide as its active ingredient (manufacturer site) ...
Clinical trials and product information show Prevnar 20 (pneumococcal 20‑valent conjugate vaccine) is generally well tolerated; the most common reactions after a dose are injection‑site pain, muscle p...
Clinical trials and systematic reviews conducted during and after the COVID-19 pandemic provide limited information about ivermectin’s long-term safety in humans; most randomized trials report short f...
Karylief is presented by vendor sites as an herbal hearing-support supplement with “most users report no side effects” and “no reports of adverse effects” . Independent third‑party coverage in the pro...
Available regulatory databases and news summaries searched here show no entry for a formal recall, warning letter, or safety review specifically naming “Laellium” by FDA or EMA; sources instead docume...
The simple answer: ; U.S. vaccine product labels show , so official ingredient counts for authorized products range from six to seven . A 2024 preprint claiming dozens of undeclared chemical elements ...
Off‑label ivermectin use can cause predictable, sometimes severe adverse effects including gastrointestinal symptoms (nausea, vomiting, diarrhea), neurologic effects (dizziness, ataxia, confusion, sei...
Regulatory agencies (FDA and EMA) approve ivermectin for specific parasitic infections in humans and not for COVID‑19; the FDA approves oral tablets for intestinal strongyloidiasis and onchocerciasis ...
Available reporting shows mixed evidence about how well recent vaccines protect against currently circulating influenza viruses: Southern Hemisphere 2025 interim data suggest roughly 50% reduction in ...
Public reporting in the supplied sources documents many high-profile accusations and public statements by Michael Yeadon in 2023–2024 alleging wrongdoing by Pfizer, regulators and governments (example...
Available sources identify at least two distinct products called “Lipoless” (a tirzepatide prescription product from Laboratorios Eticos Paraguay and several over‑the‑counter weight‑loss supplements m...
Ivermectin is an established antiparasitic used for human worm infections and topical lice/rosacea treatments; it can interact with many drugs (Drugs.com lists 106 potential drug interactions) and spe...
Lipoless — as presented on the product website — is marketed as a prescription-style injectable whose active ingredient is tirzepatide, a dual incretin agonist that mimics GLP-1 and GIP to improve ins...
Available sources in the provided set do not mention any randomized controlled trials (RCTs) that evaluated a product called “garaherb.” The search results focus on general clinical-trial coverage, tr...
Available sources do not mention a product called “Neurocept Astroncaps” and contain no international regulatory rulings specific to that name; reporting instead references Neurocrine Biosciences’ mar...